Spero Therapeutics Inc
SPRO
$1.21-0.82%
Delayed · as of Aug 25, 2026, 9:38 AM ET
Mkt cap
$149.53M
EV/Sales
1.64
P/E ratio
N/A
FY2025 Revenue
$66.80M
EPS (H1 2026)
$-0.29
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
12.83%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported SPRO revenue for 2025-12-31 was $66.8M. Net income was $8.6M. Revenue was up 39.2% from 2024-12-31 to 2025-12-31. SPRO currently screens at market cap $149.5M.
Use this SPRO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SPRO income, balance, and cash tables.
Spero Therapeutics Inc (SPRO) is a biotechnology company in the Healthcare sector.
Latest cached Spero Therapeutics Inc (SPRO) revenue for Dec 31, 2025 was $66.8M. Net income was $8.6M. Statements: https://lician.com/financials/spro
Spero Therapeutics Inc (SPRO) market capitalization is $149.5M on the latest cached snapshot.
Spero Therapeutics Inc (SPRO) cached previous close $1.22; day range $1.20 – $1.24; volume 363,540. Session quote: https://lician.com/quote/spro
Spero Therapeutics Inc (SPRO) latest cached earnings event is "SPRO earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SPRO filing is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/spro